Fourteen-week-old tumor-bearing mice mounted a robust response to PSCA and SPAS, with mean frequencies of IFN-γ-secreting CD8+ T cells of 2.9% and 9.5%, respectively (Figure 4). This evidence concerns the gene CD8A and neoplasm.